The U.S. House Appropriations committee has passed a bill that would reduce liability for chemical makers whose products have been linked to cancer.

German pharmaceutical and biotechnology group Bayer said on Thursday it had set aside an additional 1.2 billion euros ($1.37 billion) in provisions to address ongoing litigation in the United States ...